BioLineRx (BLRX) announced that it has promoted CFO Philip Serlin to CEO effective October 10. He succeeds Kinneret Savitsky, Ph.D., who will serve as a scientific advisor to the company through March 2017 before departing. The company also promoted Director of Finance and Reporting Mali Zeevi, CPA, to Chief Financial Officer effective October 10.